May 5, 2020
RegMed Investors’ (RMi) closing bell: still focusing on caution having recommended selling into strength
May 4, 2020
RegMed Investors’ (RMi) closing bell: theme words
May 1, 2020
RegMed Investors’ (RMi) closing bell: a challenged market and a low swinging sector
April 30, 2020
RegMed Investors’ (RMi) closing bell: dismal data diminishes dampened domestic debates
April 29, 2020
RegMed Investors’ (RMi) closing bell: markets moved as a treatment option, remdesivir helped patient recover more quickly
April 28, 2020
RegMed Investors’ (RMi) closing bell: yesterday’s upside strength did not sustain the sector’s share pricing today
April 24, 2020
RegMed Investors’ (RMi) closing bell: the upside feels good and shaky in the next weeks
April 23, 2020
RegMed Investors’ (RMi) closing bell: low volume volatility prevails
April 22, 2020
RegMed Investors’ (RMi) closing bell: the sector is back in an upside groove
April 21, 2020
RegMed Investors’ (RMi) closing bell: they came for the upsiders, put a black bag over their heads and dragged them out
April 20, 2020
RegMed Investors’ (RMi) closing bell: sector closed positive as indexes dived
April 17, 2020
RegMed Investors’ (RMi) closing bell: sector stocks stumbled 3 times this week, then wrestled to win with a sentiment comeback
April 16, 2020
RegMed Investors’ (RMi) closing bell: volatility is a given with the current economic destruction
April 15, 2020
RegMed Investors’ (RMi) closing bell: As I had stated, yesterday’s rally will give way to renewed selling pressure
April 14, 2020
RegMed Investors’ (RMi) closing bell: the velocity and strength of pricing needle moves dramatically due to capricious optimism
April 13, 2020
RegMed Investors’ (RMi) closing bell: never bend down for a falling knife, it could bounce off the tile and draw blood
April 9, 2020
RegMed Investors’ (RMi) closing bell: thanks for the upside, sell into the upside strength although volume is low
April 8, 2020
RegMed Investors’ (RMi) closing bell: markets are stuck in the middle of anticipation
April 7, 2020
RegMed Investors’ (RMi) closing bell: markets lose their steam minutes from the close as the sector gets ahead of reality
April 6, 2020
RegMed Investors’ (RMi) closing bell: a stabilizing event is needed in infection and death rates
April 3, 2020
RegMed Investors’ (RMi) closing bell: any gains have vanished from continued weakness
April 2, 2020
RegMed Investors’ (RMi) closing bell: What is not priced in?
April 1, 2020
RegMed Investors’ (RMi) closing bell: the cell/gene sector baby programs are being disregarded and tossed with the bathwater
March 31, 2020
RegMed Investors’ (RMi) closing bell: the cell/gene sector swings neutral as Q1 ends and markets collapse
7 hours 46 min ago
RMi Pre-opening: Drifting or still riding the witches broom?
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors
© 2025 RegMed Investors (regmedinvestors.com), all rights are reserved.
RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry McCusker. Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of Scimitar; who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other Scimitar media services or reposting please email hwm@regmedinvestors.com.
The information included above as well as individual companies and/or securities mentioned should be construed as guidance in RMi reviews.
The facts stated and the opinions given in this publication are based on data and information considered to be reliable and have been carefully worked into my qualitative analyses and prognoses. However, no guarantee can be given as to their fairness, accuracy or completeness.
Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.